Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

(2017) Francesca Minoia et al.   JOURNAL OF PEDIATRICS

International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome

(2017) Seza Ozen et al.   ARTHRITIS CARE & RESEARCH

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

(2016) Angelo Ravelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options

(2016) Ellen Brisse et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management

(2016) Akira Morimoto et al.   PEDIATRICS INTERNATIONAL

Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus

(2016) Selin Aytaç et al.   RHEUMATOLOGY INTERNATIONAL

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis

(2016) Gabriella Giancane et al.   Frontiers in Pharmacology

Macrophage activation syndrome in the course of monogenic autoinflammatory disorders

(2015) Donato Rigante et al.   CLINICAL RHEUMATOLOGY

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis

(2015) V. Boom et al.   Pediatric Rheumatology

Kikuchi disease, macrophage activation syndrome, and systemic juvenile arthritis: a new case associated with a mutation in the perforin gene

(2015) M Marsili et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period

(2015) Kenan Barut et al.   TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS

11-Month-Old Infant With Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism

(2015) Grant S. Schulert et al.   ARTHRITIS CARE & RESEARCH

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

(2014) Francesca Minoia et al.   Arthritis & Rheumatology

Urticaria, Fever, and Hypofibrinogenemia

(2014) Verena Mohr et al.   Arthritis & Rheumatology

Recurrent Macrophage Activation Syndrome Associated With Heterozygous Perforin W374X Gene Mutation in a Child with Systemic Juvenile Idiopathic Arthritis

(2013) Sule Unal et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome

(2013) P. J. KAHN et al.   JOURNAL OF RHEUMATOLOGY

Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids

(2012) Normi Bruck et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India

(2011) Surjit Singh et al.   RHEUMATOLOGY INTERNATIONAL

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients

(2010) P. M. Miettunen et al.   RHEUMATOLOGY

Anakinra for Systemic Juvenile Arthritis

(2009) Andrew Zeft et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

A case of macrophage activation syndrome successfully treated with anakinra

(2008) Alison Kelly et al.   Nature clinical practice. Rheumatology